Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

NCT04842877 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

141

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

DRUG: Valemetostat tosylate

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]